Zoetis Operating Cycle Over Time
| ZTS Stock | USD 128.67 0.54 0.42% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Zoetis Performance and Zoetis Correlation. Is there potential for Pharmaceuticals market expansion? Will Zoetis introduce new products? Factors like these will boost the valuation of Zoetis. Anticipated expansion of Zoetis directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Zoetis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.085 | Dividend Share 1.932 | Earnings Share 5.98 | Revenue Per Share | Quarterly Revenue Growth 0.005 |
The market value of Zoetis Inc is measured differently than its book value, which is the value of Zoetis that is recorded on the company's balance sheet. Investors also form their own opinion of Zoetis' value that differs from its market value or its book value, called intrinsic value, which is Zoetis' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Zoetis' market value can be influenced by many factors that don't directly affect Zoetis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zoetis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zoetis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Zoetis' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Cycle Analysis
Compare Zoetis Inc and related stocks such as Cencora, Regeneron Pharmaceuticals, and IDEXX Laboratories Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COR | 54.7342 | 45.0616 | 54.8699 | 46.1275 | 48.8977 | 50.1647 | 52.634 | 51.1441 | 48.236 | 52.3088 | 58.371 | 52.8115 | 54.1541 | 53.9508 | 52.6891 | 60.59 | 63.04 |
| REGN | 14.6 | 225 | 270 | 296 | 309 | 317 | 481 | 611 | 844 | 685 | 693 | 399 | 674 | 577 | 732 | 739 | 776 |
| IDXX | 283 | 127 | 126 | 120 | 132 | 142 | 120 | 119 | 108 | 115 | 118 | 122 | 152 | 147 | 144 | 131 | 177 |
| HLN | 293 | 293 | 293 | 293 | 293 | 293 | 293 | 293 | 293 | 293 | 222 | 245 | 182 | 156 | 160 | 184 | 231 |
| CI | 113 | 128 | 28.8224 | 28.8224 | 28.8224 | 34.3067 | 27.7154 | 28.3565 | 108 | 32.2355 | 35.7865 | 39.6356 | 45.4171 | 44.7324 | 46.5888 | 53.58 | 50.9 |
| ELV | 27.6388 | 26.1335 | 28.7473 | 25.8602 | 34.3018 | 32.3894 | 36.1176 | 35.6487 | 36.8983 | 36.3939 | 32.82 | 35.384 | 37.3962 | 38.0572 | 39.3695 | 39.5736 | 25.35 |
| BDX | 184 | 180 | 188 | 183 | 188 | 144 | 161 | 156 | 154 | 162 | 140 | 156 | 154 | 182 | 169 | 195 | 211 |
| ELAN | 281 | 281 | 281 | 281 | 281 | 281 | 281 | 302 | 291 | 335 | 404 | 265 | 313 | 339 | 300 | 270 | 252 |
| ARGX | 247 | 247 | 95.0635 | 150 | 127 | 72.2119 | 52.9154 | 30.07 | 54.1502 | 148 | 78.6163 | 96.6353 | 3.1 K | 1.1 K | 280 | 252 | 321 |
| TAK | 210 | 220 | 212 | 243 | 245 | 231 | 209 | 213 | 569 | 272 | 289 | 278 | 270 | 287 | 267 | 240 | 191 |
Zoetis Inc and related stocks such as Cencora, Regeneron Pharmaceuticals, and IDEXX Laboratories Operating Cycle description
My Equities
My Current Equities and Potential Positions
| Zoetis Inc | ZTS |
| Classification | SRI Sustainable Growth |
| Business Address | 10 Sylvan Way, |
| Exchange | New York Stock Exchange |
USD 128.67
Additional Tools for Zoetis Stock Analysis
When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.